Introducing the new AltIndexLearn more
51 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
+2 pts over 3 months0% of AXGN’s tracked signals bullish
FundamentalsNeutral
TechnicalsNeutral
Alternative dataNeutral
SentimentBearish
Price$41.29
Year Range$22.22 – $46.19
Market Cap$2.32B
IndustryMedical Devices

What Is Axogen’s AI Stock Analysis?

Axogen’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Axogen’s momentum in near-real time.

Axogen (AXGN) has an AltIndex AI Score of 51/100, currently a Hold signal. The AI Score distills Axogen's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Axogen’s Full AI Analysis

Axogen Inc. is a leading company in the field of regenerative medicine, specifically focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company’s products are designed to benefit patients with peripheral nerve damage by providing solutions that support nerve repair and care during surgery.

Fundamental Analysis

Axogen's revenue for the last quarter was $61 million, showing a growth of 2.59% compared to the previous quarter. This is an encouraging sign of quarter-over-quarter growth. Year-over-year, the revenue has increased by 26.56%, indicating strong annual growth.

However, the net income for the last quarter stood at -$20 million, highlighting a steep decline of 48.86% compared to the quarter before. Compared to the same quarter the previous year, net income has decreased by a significant 410.80%, raising serious concerns about the company's profitability and cost management.

Premium

Keep reading AltIndex’s full AI analysis of Axogen — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving AXGN’s AI Score?

Fundamentals

Revenue for the last quarter was $61M. This is an increase of 2.59% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 26.56%, suggesting positive year-over-year growth. Net income for the last quarter was $-20M. This represents a decrease of 48.86% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 410.80%, which may be a cause for concern. Ebitda for the last quarter was $-2.8M. This is an increase of -66.68% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 1,050.34%, which may be a cause for concern. In the last couple of months, there's been a couple of company insiders selling their stock, a potentially bearish signal.

See Axogen’s earnings and insider transactions.

Technicals

Today's stock price is $40.73. This represents a decrease of 1.48% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 242.56%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $44.52, which is lower than the previous SMA10 of $45.07. This suggests a potential downward trend in price movement. The RSI is 69.7, indicating a neutral condition.

See the full technical analysis and price prediction.

Alternative data

Axogen has an estimated 16 open positions and this number has been stable over the last couple of months indicating a company in a stable position. The business outlook among employees at Axogen is low (an estimate of only 44% of employees have a positive outlook), a concerning sign. But the business outlook has been trending up by 19% in the last couple of months, a positive trend. Axogen has an estimate of 22,000 visitors to their webpage. The number of visitors is down by -33% in the last couple of months, a worrisome trend as this can indicate a loss in customers.

Explore Axogen’s job postings, web traffic and app downloads.

Sentiment & social

Axogen has 2,500 followers on their Instagram page, with no meaningful increase or decrese in the last couple of months. Axogen has 920 followers on their Twitter page. The number of followers is down by -1% in the last couple of months, indicating a loss in interest in the company.

Track Axogen’s market sentiment.

Frequently Asked Questions: Axogen AI Stock Analysis

Axogen's AltIndex AI Score is 51/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Axogen a Hold (51/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Axogen — company overview, fundamentals, technicals and alternative data, with a recommendation. See the AXGN AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.